Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto que contiene benzocaína y mepiramina en forma farmacéutica para administración cutánea como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | antihistamínico, forma farmacéutica tópica | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con mepiramina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con benzocaína | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | antihistamínico sedante (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | agente dermatológico | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | Mepyramine | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | Benzocaine (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | maleato de pirilamina+benzocaína (producto) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | Mepyramine maleate | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | mepiramina (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene como ingrediente activo | Ethylenediamine derivative antihistamine | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has manufactured dose form | forma farmacéutica cutánea Y/O transdérmica (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con benzocaína y mepiramina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto elaborado como forma farmacéutica para administración tópica (producto) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto que contiene mepiramina en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto que contiene benzocaína en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has manufactured dose form | Cutaneous spray | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Benzocaine (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene base de sustancia de la potencia | Benzocaine (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | recuento de bases de ingrediente activo | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene base de sustancia de la potencia | Mepyramine maleate | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene valor de numerador de potencia de concentración | 20 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Mepyramine maleate | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene valor de numerador de potencia de concentración | 20 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets